This article contains text that is written in a promotional tone .(September 2023) |
Emmanouil T. Dermitzakis | |
---|---|
Born | Emmanouil Theophilos Dermitzakis April 3, 1972 |
Nationality | Greek |
Education | University of Crete Pennsylvania State University |
Spouse | Yes |
Children | 3 |
Scientific career | |
Fields | Genomics Population genetics |
Institutions | University of Geneva |
Thesis | Evolution of components of gene regulation in Drosophila and mammals (2001) |
Doctoral advisor | Andrew G. Clark |
Emmanouil Theophilos Dermitzakis (born April 3, 1972) is a Greek human geneticist and professor in the Department of Genetic Medicine and Development at the University of Geneva, where he is also Director of the Health 2030 Genome Center. He is an ISI Highly Cited Researcher and an elected member of the European Molecular Biology Organization. [1] [2] He is a member of the Swiss Institute of Bioinformatics, where his research group is focused on the genetics and genomics of complex traits in humans. [3] He has joined GlaxoSmithKline as Vice President, Computational Biology in R&D. [4]
Dermitzakis graduated from High School in Pagrati, Athens. His dream of becoming a geneticist was spurred by two pages on genetic engineering in a Biology book in the school curriculum. [5] His father was a physician and former classmate of professor Fotis Kafatos, who inspired him to later enter the field of research. [6]
Dermitzakis completed his graduate degree in Biology at the University of Crete in 1995 and then earned a Master of Science at the same University in 1997. [7] During an interview he confessed that he did not achieve a high score in his first degree, nevertheless his drive for research helped him pursue doctoral studies in the USA. [6] He completed his doctoral thesis in the evolution of components of gene regulation in Drosophila and mammals at Penn State University in 2001. [7] He then completed postdoctoral studies at the Medical School of the University of Geneva in 2004 with his research on comparative genome analysis and the functional characterization of conserved non-genic elements. [8]
After completing his studies Dermitzakis moved to the United Kingdom, where he worked as a group leader and member of the academic council at the Wellcome Sanger Institute from 2004 to 2009. [9] He continued his research career in Switzerland, as Professor of Genetics in the Department of Genetic Medicine and Development at the University of Geneva and in research centres including Frontiers in Genetics and the Swiss Institute of Bioinformatics in Geneva. [10] He has served as Director of the Health 2030 Genome Center and is a member of the Biomedical Research Foundation of the Academy of Athens in Greece. [6] In November 2019 he was appointed chairman of the Greek National Council for Research, Technology and Innovation, however a few months later he resigned, having said that his role on the council was merely decorative. [11] In October 2020 he was appointed Director of the Institute of Genetics and Genomics of Geneva (known also as iGE3). [12]
Dermitzakis has published over 160 papers in peer-reviewed scientific journals such as Nature and Science with over 89,000 citations. [13] Before the age of 40 he was already on the Thomson Reuters Highly Cited Researchers list in the field of Molecular Biology and Genetics. [14] His research has been funded by the European Research Council (ERC), the European Union, the Swiss National Science Foundation, the American National Institutes of Health (NIH), the Wellcome Trust, the Juvenile Diabetes Research Foundation (JDRF) and the Louis-Jeantet Foundation. [15] Dermitzakis has earned numerous awards and continues to appear on the ISI Highly Cited Researchers List every year from 2014 onward. [16]
Dermitzakis has been one of the first scientists to reveal the importance of non-coding DNA in evolution and disease susceptibility. His papers on the evolution of regulatory elements showed the dynamic nature of regulatory sequences. [17] His group has pioneered the analysis of non-coding regulatory variants in the human genome and their effect on gene expression regulation, [18] [19] [20] [21] [22] chromatin patterns and regulatory interactions [23] [24] and 3D genome interactions in cis and trans regulatory variants [25] and how they are impacting cellular function as well as disease susceptibility [26] [27] and cancer. [28]
He has participated in international genetics projects such as ENCODE, [29] HapMap, [30] GTEx [31] and more recently in the International Common Disease Alliance (ICDA). [32]
Manolis Dermitzakis is married to attorney Ria Kechagia and the couple have three children. [33]
A transposable element is a nucleic acid sequence in DNA that can change its position within a genome, sometimes creating or reversing mutations and altering the cell's genetic identity and genome size. Transposition often results in duplication of the same genetic material. In the human genome, L1 and Alu elements are two examples. Barbara McClintock's discovery of them earned her a Nobel Prize in 1983. Its importance in personalized medicine is becoming increasingly relevant, as well as gaining more attention in data analytics given the difficulty of analysis in very high dimensional spaces.
The human genome is a complete set of nucleic acid sequences for humans, encoded as DNA within the 23 chromosome pairs in cell nuclei and in a small DNA molecule found within individual mitochondria. These are usually treated separately as the nuclear genome and the mitochondrial genome. Human genomes include both protein-coding DNA sequences and various types of DNA that does not encode proteins. The latter is a diverse category that includes DNA coding for non-translated RNA, such as that for ribosomal RNA, transfer RNA, ribozymes, small nuclear RNAs, and several types of regulatory RNAs. It also includes promoters and their associated gene-regulatory elements, DNA playing structural and replicatory roles, such as scaffolding regions, telomeres, centromeres, and origins of replication, plus large numbers of transposable elements, inserted viral DNA, non-functional pseudogenes and simple, highly repetitive sequences. Introns make up a large percentage of non-coding DNA. Some of this non-coding DNA is non-functional junk DNA, such as pseudogenes, but there is no firm consensus on the total amount of junk DNA.
Molecular genetics is a branch of biology that addresses how differences in the structures or expression of DNA molecules manifests as variation among organisms. Molecular genetics often applies an "investigative approach" to determine the structure and/or function of genes in an organism's genome using genetic screens.
Gene duplication is a major mechanism through which new genetic material is generated during molecular evolution. It can be defined as any duplication of a region of DNA that contains a gene. Gene duplications can arise as products of several types of errors in DNA replication and repair machinery as well as through fortuitous capture by selfish genetic elements. Common sources of gene duplications include ectopic recombination, retrotransposition event, aneuploidy, polyploidy, and replication slippage.
The International HapMap Project was an organization that aimed to develop a haplotype map (HapMap) of the human genome, to describe the common patterns of human genetic variation. HapMap is used to find genetic variants affecting health, disease and responses to drugs and environmental factors. The information produced by the project is made freely available for research.
Functional genomics is a field of molecular biology that attempts to describe gene functions and interactions. Functional genomics make use of the vast data generated by genomic and transcriptomic projects. Functional genomics focuses on the dynamic aspects such as gene transcription, translation, regulation of gene expression and protein–protein interactions, as opposed to the static aspects of the genomic information such as DNA sequence or structures. A key characteristic of functional genomics studies is their genome-wide approach to these questions, generally involving high-throughput methods rather than a more traditional "candidate-gene" approach.
Genome size is the total amount of DNA contained within one copy of a single complete genome. It is typically measured in terms of mass in picograms or less frequently in daltons, or as the total number of nucleotide base pairs, usually in megabases. One picogram is equal to 978 megabases. In diploid organisms, genome size is often used interchangeably with the term C-value.
In biology, the word gene has two meanings. The Mendelian gene is a basic unit of heredity. The molecular gene is a sequence of nucleotides in DNA, that is transcribed to produce a functional RNA. There are two types of molecular genes: protein-coding genes and non-coding genes.
Human genetic variation is the genetic differences in and among populations. There may be multiple variants of any given gene in the human population (alleles), a situation called polymorphism.
Expression quantitative trait loci (eQTLs) are genomic loci that explain variation in expression levels of mRNAs.
Stephen Wayne "Steve" Scherer is a Canadian scientist who currently serves as the Chief of Research at The Hospital for Sick Children (SickKids) and distinguished University Professor at the University of Toronto. He obtained his PhD at the University of Toronto under Professor Lap-chee Tsui. Together they founded Canada's first human genome centre, the Centre for Applied Genomics (TCAG). He is a Senior Fellow of Massey College at the University of Toronto. In 2014, he was named an esteemed Clarivate Citation laureate in Physiology or Medicine for the “Discovery of large-scale gene copy number variation and its association with specific diseases.”
Ross C. Hardison is an American biochemist and molecular biologist, currently the T. Ming Chu Professor of Biochemistry and Molecular Biology at the Eberly College of Science, of the Pennsylvania State University.
Manolis Kellis is a professor of Computer Science at the Massachusetts Institute of Technology (MIT) in the area of Computational Biology and a member of the Broad Institute of MIT and Harvard. He is the head of the Computational Biology Group at MIT and is a Principal Investigator in the Computer Science and Artificial Intelligence Lab (CSAIL) at MIT.
Yi Zhang is a Chinese-American biochemist who specializes in the fields of epigenetics, chromatin, and developmental reprogramming. He is a Fred Rosen Professor of Pediatrics and professor of genetics at Harvard Medical School, a senior investigator of Program in Cellular and Molecular Medicine at Boston Children's Hospital, and an investigator of the Howard Hughes Medical Institute. He is also an associate member of the Harvard Stem Cell Institute, as well as the Broad Institute of MIT and Harvard. He is best known for his discovery of several classes of epigenetic enzymes and the identification of epigenetic barriers of SCNT cloning.
John A. Stamatoyannopoulos a Greek-American physician-scientist in molecular biology and epigenomics. He is a professor of genome sciences and medicine at the University of Washington, where he heads the Stam Lab and led UW Medicine's participation in the ENCODE project. John is the son of Greek geneticist George Stamatoyannopoulos. Stamatoyannopoulos currently serves as scientific director at the Altius Institute for Biomedical Sciences.
Bart Deplancke is a Belgian bio-engineer and researcher. He is a full professor at École Polytechnique Fédérale de Lausanne, where he leads the laboratory of systems biology and genetics.
Barbara Elizabeth Engelhardt is an American computer scientist and specialist in bioinformatics. Working as a Professor at Stanford University, her work has focused on latent variable models, exploratory data analysis for genomic data, and QTLs. In 2021, she was awarded the Overton Prize by the International Society for Computational Biology.
Tara Matise is an American geneticist at Rutgers University. Since 2018, she has served as chair of the Department of Genetics. Her research interests span computational genetics, data science, and human genetics. She is co-director of the Rutgers University Genetics Coordinating Center.
Stein Aerts is a Belgian bio-engineer and computational biologist. He leads the Laboratory of Computational Biology at VIB and KU Leuven, and is director of VIB.AI, the VIB Center for AI & Computational Biology. He has received several accolades for his research into the workings of the genomic regulatory code.
Sagiv Shifman is an Israeli scientist, professor in the field of neurogenetics at the Alexander Silberman Institute of Life Sciences, The Hebrew University of Jerusalem. He holds the Arnold and Bess Zeldich Ungerman chair in Neurobiology.
{{cite journal}}
: CS1 maint: numeric names: authors list (link)